Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic imipramine, L-sulpiride and mianserin decrease corticotropin releasing factor levels in the rat brain

P Fadda1, L Pani, A Porcella

  • 1B.B. Brodie Department of Neuroscience, University of Cagliari, Italy.

Neuroscience Letters
|June 9, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An overall view of the most common experimental models for multiple sclerosis.

Neurobiology of disease·2023
Same author

Systematic Data Monitoring and Analysis of Cardiovascular Off-label Prescriptions in Pediatrics: Focus on Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Beta Blockers.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2022
Same author

Impact of reimbursement limits on patient access to direct-acting antivirals in Italy: analysis of data from national registries.

European review for medical and pharmacological sciences·2020
Same author

Methoxetamine affects brain processing involved in emotional response in rats.

British journal of pharmacology·2017
Same author

Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways.

Clinical pharmacology and therapeutics·2016
Same author

The future is now: model-based clinical trial design for Alzheimer's disease.

Clinical pharmacology and therapeutics·2015

Chronic antidepressant treatment, including mianserin, lowers corticotropin-releasing factor (CRF) in the hypothalamus. Mianserin uniquely reduces extrahypothalamic CRF, suggesting a novel therapeutic mechanism for this atypical antidepressant.

Area of Science:

  • Neuropharmacology
  • Endocrinology

Background:

  • Mianserin's antidepressant action is linked to corticotropin-releasing factor (CRF) variations.
  • Understanding CRF modulation by antidepressants is crucial for elucidating therapeutic mechanisms.

Purpose of the Study:

  • To investigate the specific effects of chronic antidepressant treatment on CRF levels in different brain regions.
  • To compare the CRF-modulating effects of mianserin, imipramine, and L-sulpiride.

Main Methods:

  • Rats received chronic treatment with mianserin, imipramine, or L-sulpiride.
  • CRF concentrations were measured in the hypothalamus and extrahypothalamic sites.
  • Acute and chronic treatment effects were assessed.

Main Results:

Related Experiment Videos

  • All tested antidepressants significantly decreased hypothalamic CRF levels after chronic administration.
  • Only mianserin demonstrated a significant 40% reduction in extrahypothalamic CRF concentrations.
  • Acute treatments did not alter CRF levels, and chronic mianserin did not affect CRF density.

Conclusions:

  • Chronic mianserin exhibits a unique ability to decrease extrahypothalamic CRF levels, differentiating it from imipramine and L-sulpiride.
  • This finding may contribute to the atypical therapeutic profile of mianserin.
  • CRF modulation in extrahypothalamic regions represents a potential target for antidepressant drug development.